Science

Mar 17, 2025, 09:24

Myeloma Paper of the Day, March 17th, suggested by Robert Orlowski

Robert Orlowski, Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson Cancer Center, shared a post on X:

“Myeloma Paper of the Day: US MM Immunotherapy Consortium study suggests universal driving restrictions beyond 4 weeks appear unnecessary following CAR-T therapy in myeloma, vs. FDA and EMA guidance of 8 weeks.”

“Universal driving restrictions beyond 4 weeks appear unnecessary following CAR-T therapy in multiple myeloma”

Authors: Rahul Banerjee, Alicia Richards, Shonali Midha, Aimaz Afrough, Faiz Anwer, Thomas Martin, Peter Voorhees, Larry Anderson, Jr., Andrew Cowan, Gurbakhash Kaur et al.

More posts featuring Robert Orlowski.

Aimaz Afrough Alicia Richards Andrew Cowan cancer CAR-T therapy Faiz Anwer Gurbakhash Kaur Larry Anderson Jr MM multiple myeloma Myeloma Paper of the Day OncoDaily Oncology Peter Voorhees Rahul Banerjee Robert Orlowski Shonali Midha Thomas Martin

FDA Approves Nivolumab and Ipilimumab for First-Line Treatment of Unresectable Hepatocellular Carcinoma Based on CheckMate-9DW Trial

John Cena Announces He Overcame Skin Cancer Twice, Advocates for Sun Safety

William N. Hait to Receive 2025 AACR-Margaret Foti Award for Leadership in Cancer Research

Stella Kyriakides joins ESO as Co-Chair and Senior Lecturer in Cancer Policy to Guide the 2026–2028 Strategic Plan

FDA Approves Nivolumab and Ipilimumab for Unresectable or Metastatic MSI-H or dMMR Colorectal Cancer: CheckMate 8HW trial results